Flyer

Quanterix empowers researchers with cutting-edge Simoa® digital immunoassays that measure both established and emerging biomarkers in neurology. Simoa® technology sets the gold standard for early biomarker detection in serum, plasma, or CSF, quantifying proteins at levels far below the conventional ELISA Level of Quantification (LoQ). Rely on our industry-leading precision instruments, Simoa® digital immunoassay technology, and CLIA-certified Accelerator laboratory to support research that advances our understanding and management of neurological disorders. Download our flyer to learn more.